<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>10840228302503</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>REFRESH OPHTHALMIC</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>95390FR</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-24T09:56:16.947Z</lastUpdated>
  </row>
  <row>
    <udiDi>05016007205497</udiDi>
    <basicUdiDi>0840228300014B</basicUdiDi>
    <tradeName>Skin Marking Grid</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>SKIN MARKING DERMOGRAPHIC PENCILS AND PENS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>95729EU</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-06-22T12:14:40.443Z</lastUpdated>
  </row>
  <row>
    <udiDi>05016007206357</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION UD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>97034AQ</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T12:14:40.415Z</lastUpdated>
  </row>
  <row>
    <udiDi>05016007206388</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE FUSION MD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>97033MW</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T12:14:40.377Z</lastUpdated>
  </row>
  <row>
    <udiDi>05016007207583</udiDi>
    <basicUdiDi>B-05016007207583</basicUdiDi>
    <tradeName>XEN 63 GLAUCOMA TREATMENT SYSTEM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>GLAUCOMA DRAINAGES AND KITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>5501-001</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-06-22T12:14:40.352Z</lastUpdated>
  </row>
  <row>
    <udiDi>10888628032439</udiDi>
    <basicUdiDi>B-10888628032439</basicUdiDi>
    <tradeName>XEN 45 GLAUCOMA TREATMENT SYSTEM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>5507-001</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T13:13:42.223Z</lastUpdated>
  </row>
  <row>
    <udiDi>10888628043725</udiDi>
    <basicUdiDi>0840228300064M</basicUdiDi>
    <tradeName>Keller Funnel 2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Quality First International OÜ</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>EE-AR-000004308</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HA-005</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T13:13:42.207Z</lastUpdated>
  </row>
  <row>
    <udiDi>10888628043732</udiDi>
    <basicUdiDi>0840228300064M</basicUdiDi>
    <tradeName>Keller Funnel 2</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Quality First International OÜ</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>EE-AR-000004308</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HA-001</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T13:13:42.178Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300462</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:37.091Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300486</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:37.066Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300509</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:37.040Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300523</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:37.022Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300530</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:37.004Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300578</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:36.966Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300622</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:36.942Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300639</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:36.920Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300646</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:36.901Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300653</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:36.875Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300684</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:36.852Z</lastUpdated>
  </row>
  <row>
    <udiDi>10840228300691</udiDi>
    <basicUdiDi>0840228300034F</basicUdiDi>
    <tradeName>OPTIVE PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Allergan Sales, LLC</manufacturerName>
    <manufacturerSrn>US-MF-000001517</manufacturerSrn>
    <authorisedRepresentativeName>Allergan Pharmaceuticals International Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000650</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-30T13:39:36.831Z</lastUpdated>
  </row>
</eudamedExport>